West Windsor, NJ, United States of America

Kevin G Liu

This inventor holds 17 USPTO granted patents and 12 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Kadmon Corporation, LLC, Wyeth, Kadmon Corportion, LLC. Active years: 2009-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kevin G Liu. Retrieved from https://idiyas.com/inventor/kevin-g-liu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 (Patent Applications = 12)

% Patents Active = 76.5

CIPO Patents = 1 (Patent Applications = 10)

EPO Patents = 2 (Patent Applications = 9)

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 13(Granted Patents)

Company Filing History:

11 out of 23

Kadmon Corporation, LLC

Kadmon Corportion, LLC

patent

4. 1 out of 4

Meiragtx Gene Regulation Limited

patents

Years Active: 2009-2026

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12570988 - Aptamers That Bind Thiamine Analogs and Derivatives (2026-03-10),

2. 12030857 - Glucose uptake inhibitors (2024-07-09),

3. 11926596 - Inhibitors of Rho associated coiled-coil containing protein kinase (2024-03-12),

4. 11613531 - Inhibitors of RHO associated coiled-coil containing protein kinase (2023-03-28),

5. 11479533 - Inhibitors of Rho associated coiled-coil containing protein kinase (2022-10-25),

6. 11071735 - Treatment of inflammatory conditions and autoimmune diseases with glucose uptake inhibitors (2021-07-27),

7. 10988484 - Glucose uptake inhibitors (2021-04-27),

8. 10729691 - Treatment of infectious diseases with glucose uptake inhibitors (2020-08-04),

9. 10696660 - Rho kinase inhibitors (2020-06-30),

10. 10273248 - Glucose uptake inhibitors (2019-04-30),

11. 10183931 - Rho kinase inhibitors (2019-01-22),

12. 10125144 - Rho kinase inhibitors (2018-11-13),

13. 9815820 - Rho kinase inhibitors (2017-11-14),

14. 7790751 - Azinyl-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands (2010-09-07),

15. 7723329 - Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands (2010-05-25),

Title: The Innovative Journey of Kevin G Liu

Introduction: Kevin G Liu, a talented inventor hailing from West Windsor, NJ (US), has made significant contributions to the world of innovations with his creative mind and dedication.

Latest Patents: Kevin G Liu's latest patents showcase his expertise in various fields, including technology, healthcare, and sustainable energy. His recent inventions have been at the forefront of cutting-edge advancements in the industry.

Career Highlights: Throughout his illustrious career, Kevin G Liu has been recognized for his groundbreaking inventions that have revolutionized the way we live and work. His commitment to pushing the boundaries of innovation has earned him a reputation as a visionary in the field.

Collaborations: Kevin G Liu has collaborated with leading companies, research institutions, and universities to bring his ideas to life. His partnerships have been instrumental in turning his innovative concepts into tangible products that have had a lasting impact on society.

Conclusion: In conclusion, Kevin G Liu's passion for innovation, coupled with his relentless drive to create, has solidified his position as a pioneering inventor. His contributions to the world of inventions continue to inspire future generations to think outside the box and pursue their creative endeavors.

Profile summary based on public USPTO records.